Patients taking opioids produce antibodies that may hinder anti-opioid vaccine

From the August 17, 2020 news release at the University of Wisconsin-Madison

“University of Wisconsin–Madison scientists have discovered that a majority of people they tested who were taking opioid painkillers for chronic back pain produced antibodies against the drugs that may contribute to some of the negative side effects of long-term opioid use.”
…

…”For decades, researchers have understood that the immune system can produce antibodies against psychoactive drugs under the right conditions. While the chemicals themselves are too small for the immune system to recognize, they can permanently bind to large proteins in the blood, which can then trigger an immune response.”…

Read the entire article here

…”If a vaccine can produce antibodies capable of neutralizing the drugs, it could help people combat addiction by reducing the pleasurable feelings the drugs produce in the brain. Past trials of vaccines against nicotine or cocaine have had limited success, in part because of individual differences in how the immune system produces antibodies.”…

——————–
Related article & 3 minute video
Negative side effects of opioids could be coming from users’ own immune systems (video) (American Chemical Society, August 17, 2020)

This video, in 3 minutes, summarizes the University of Madison-Wisconsin article

Flu Virus Wipes out Immune System’s First Responders to Establish Infection

From the 20 October 2013 article at Science Daily

Revealing influenza’s truly insidious nature, Whitehead Institute scientists have discovered that the virus is able to infect its host by first killing off the cells of the immune system that are actually best equipped to neutralize the virus.

Confronted with a harmful virus, the immune system works to generate cells capable of producing antibodies perfectly suited to bind and disarm the hostile invader. These virus-specific B cells proliferate, secreting the antibodies that slow and eventually eradicate the virus. A population of these cells retains the information needed to neutralize the virus and takes up residence in the lung to ward off secondary infection from re-exposure to the virus via inhalation.

…

Read the entire article here

Related articles

• Researchers Discover How Flu Gains Foothold in the Body (news.health.com)
• Researchers Discover How Flu Gains Foothold in the Body (oddonion.com)
• Super Flu Vaccine Eliminates All Strains of the Virus (americanlivewire.com)
• Universal flu vaccine ‘blueprint’ (bbc.co.uk)
• How vaccines work (missvenecia.wordpress.com)
• Top Ten Myths About The Flu (charlotte.cbslocal.com)

 

Economics and evolution help scientists identify new strategy to control antibiotic resistance

Image via Wikipedia

Economics and evolution help scientists identify new strategy to control antibiotic resistance

From the March 18 2011 Science Daily news article

ScienceDaily (Mar. 20, 2011) — A team of scientists from the University of Oxford, U.K. have taken lessons from Adam Smith and Charles Darwin to devise a new strategy that could one day slow, possibly even prevent, the spread of drug-resistant bacteria. In a new research report published in the March 2011 issue of Genetics, [Abstract***]the scientists show that bacterial gene mutations that lead to drug resistance come at a biological cost not borne by nonresistant strains. They speculate that by altering the bacterial environment in such a way to make these costs too great to bear, drug-resistant strains would eventually be unable to compete with their nonresistant neighbors and die off.

“Bacteria have evolved resistance to every major class of antibiotics, and new antibiotics are being developed very slowly; prolonging the effectiveness of existing drugs is therefore crucial for our ability to treat infections,” said Alex Hall, Ph.D., a researcher involved in the work from the Department of Zoology at the University of Oxford. “Our study shows that concepts and tools from evolutionary biology and genetics can give us a boost in this area by identifying novel ways to control the spread of resistance.”

The research team measured the growth rates of resistant and susceptible Pseudomonas aeruginosa bacteria in a wide range of laboratory conditions. They found that the cost of antibiotic resistance has a cost to bacteria, and can be eliminated by adding chemical inhibitors of the enzyme responsible for resistance to the drug. Leveling the playing field increased the ability of resistant bacteria to compete effectively against sensitive strains in the absence of antibiotics. Given that the cost of drug resistance plays an important role in preventing the spread of resistant bacteria, manipulating the cost of resistance may make it possible to prevent resistant bacteria from persisting after the conclusion of antibiotic treatment. For instance, new additives or treatments could render antibiotic resistance more costly for bacteria, making it less likely that the resistant strains will persist at the end of treatment.

“If we’ve learned one thing about microscopic organisms over the past century, it’s that they evolve quickly, and that we can’t stop the process,” said Mark Johnston, Editor-in-Chief of the journal GENETICS. “This research turns this fact against the bacteria. This is an entirely new strategy for extending the useful life of antibiotics, and possibly for improving the potency of old ones.”

***For suggestions on how to get this article for free or at low cost click here

Related Articles

• Antibiotic resistance is not just genetic (sciencedaily.com)
• Pollution with antibiotics leads to resistant bacteria (physorg.com)
• Hospital infections: Unique antibody from llamas provide weapon against Clostridium difficile (ScienceDaily [news article])